June 29, 2020 / 6:23 AM / 5 days ago

BRIEF-Tiziana Life Sciences Says Agreement For Gmp Manufacturing Of Anti-Interleukin-6-Receptor Monoclonal Antibody For Clinical Studies

June 29 (Reuters) - Tiziana Life Sciences PLC:

* TIZIANA LIFE SCIENCES -AGREEMENT FOR GMP MANUFACTURING OF ANTI-INTERLEUKIN-6-RECEPTOR MONOCLONAL ANTIBODY FOR CLINICAL STUDIES IN PATIENTS WITH COVID Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below